Artificial intelligence (AI) can predict how well patients with rectal cancer will respond to treatment by analyzing standard tissue samples taken during diagnosis, finds a new study from researchers ...

A real-world analysis of nearly 7000 patients shows GLP-1s are associated with sharply lower death rates at 5 years in ...

A recent UCLA study revealed that fewer than one in four eligible adults aged 45-49 underwent colorectal cancer screening ...

UCLA research finds that fewer than one in four eligible younger adults completed colorectal cancer screenings after the ...

UCLA research finds that fewer than 1 in 4 eligible younger adults completed colorectal cancer screenings after the United States Preventive Services Task Force (USPSTF) lowered the recommended ...

Artificial intelligence (AI) can predict how well patients with rectal cancer will respond to treatment by analyzing standard ...

Worldwide, colorectal cancer is the second leading cause of cancer-related mortality and the third most common cancer, with incidence rates increasing among individuals younger than 50 years.1 ...

Artios Pharma is working on a pipeline of oncology assets, led by alnodesertib, currently being tested for second-line ...

One study found that vitamin D may have anticancer effects, which could help reduce colorectal cancer risk. Another piece of ...

The observational study found that women who reported consuming nine to 10 daily servings of ultra-processed foods seemed to ...

"Not all colon polyps are cancerous but all colon cancer starts as a polyp which is why everyone needs to know about them and ...

People with colon cancer who took GLP-1 drugs were less likely to die within 5 years than people not on GLP-1s, a new study ...